Richard W. Paul & Associates’s iShares Biotechnology ETF IBB Stock Holding History

Richard W. Paul & Associates’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.33K	Hold	28	–	–	﹤0.01%	256
2026 Q1	$4.73K	Hold	28	–	–	﹤0.01%	236
2025 Q4	$4.73K	Sell	28 -7,429	-100%	-$1.21M	﹤0.01%	236
2025 Q3	$1.08M	Buy	7,457 +168	+2%	+$22.9K	0.37%	69
2025 Q2	$922K	Buy	7,289 +560	+8%	+$68.7K	0.33%	74
2025 Q1	$861K	Sell	6,729 -62	-0.9%	-$8.41K	0.34%	73
2024 Q4	$898K	Buy	6,791 +68	+1%	+$9.56K	0.33%	82
2024 Q3	$979K	Buy	6,723 +53	+0.8%	+$7.67K	0.35%	78
2024 Q2	$916K	Buy	6,670 +944	+16%	+$126K	0.35%	76
2024 Q1	$786K	Buy	5,726 +462	+9%	+$63.1K	0.31%	86
2023 Q4	$715K	Buy	5,264 +4,895	+1,327%	+$597K	0.3%	87
2023 Q3	$45.1K	Hold	369	–	–	0.02%	210
2023 Q2	$46.8K	Hold	369	–	–	0.02%	225
2023 Q1	$47.7K	Hold	369	–	–	0.02%	221
2022 Q4	$48.4K	Buy	+369	New	+$47.7K	0.02%	219

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Richard W. Paul & Associates's IBB Position: Q2 2026 in Review

Richard W. Paul & Associates held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 28 shares worth $5.33K. The position accounts for ﹤0.01% of the portfolio, ranked #256.

Richard W. Paul & Associates first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.08M in Q3 2025. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Richard W. Paul & Associates held 28 shares of iShares Biotechnology ETF worth $5.33K as of Q2 2026.
Richard W. Paul & Associates left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Richard W. Paul & Associates's portfolio in Q2 2026, its #256 holding.
Richard W. Paul & Associates first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
Richard W. Paul & Associates's iShares Biotechnology ETF position peaked at $1.08M in Q3 2025.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Richard W. Paul & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.